WHO Operations Disrupted After Attacks on Gaza Warehouse and Staff Shelter
WHO Strongly Condemns Attacks on Staff Shelter and Warehouse in Gaza as Humanitarian Health Operations Reach Breaking Point The World Health Organization (WHO) has issued a forceful condemnation of recent…
WuXi Biologics Gets FDA Nod for Five Sites, Including First Commercial PFS Line
WuXi Biologics Achieves Major Regulatory Milestone with FDA Pre-License Inspection Clearance for Five Facilities, Including First Commercial Pre-Filled Syringe Site WuXi Biologics (HKEX: 2269), a global leader in Contract Research,…
Bristol Myers’ sNDA for Sotyktu in Psoriatic Arthritis Accepted in Four Global Regions
Bristol Myers Squibb’s Sotyktu Makes Global Regulatory Progress for Psoriatic Arthritis as FDA Accepts sNDA for Review In a major development for immunology-focused therapeutics, Bristol Myers Squibb (NYSE: BMY) has…
Sarepta Therapeutics Issues Update on ELEVIDYS Program
Sarepta Therapeutics Responds to FDA’s Voluntary Halt Request for ELEVIDYS Shipments and Clarifies Gene Therapy Safety Concerns Sarepta Therapeutics, Inc. (NASDAQ: SRPT), a leading biotechnology company at the forefront of…
Genentech Updates sBLA for Columvi Combo in R/R DLBCL
Genentech Receives FDA Complete Response Letter for Columvi Combination Therapy in Second-Line Diffuse Large B-Cell Lymphoma; Reaffirms Commitment to Advancing Columvi Across the Treatment Landscape Genentech, a member of the…
Wedgewood Enhances Veterinary Expertise with Two New Advisory Councils
Wedgewood Expands and Evolves Its Veterinary Advisory Committee with the Launch of Two New Councils to Strengthen Clinical Collaboration and Strategic Insight Wedgewood, a long-standing leader in veterinary pharmacy and…
MEI Pharma raises $100M, adopts Litecoin treasury plan, and adds Charlie Lee to board
MEI Pharma Makes Historic Move with $100 Million Private Placement to Launch Litecoin-Based Treasury Strategy, Appoints Charlie Lee to Board In a bold and unprecedented move that bridges the worlds…
Bristol Myers Squibb Reports Phase 3 Results for Reblozyl in Myelofibrosis Anemia
Bristol Myers Squibb Reports Topline Results from Phase 3 INDEPENDENCE Trial of Reblozyl in Myelofibrosis-Associated Anemia Bristol Myers Squibb (NYSE: BMY), a global leader in hematology and oncology innovation, has…
Propel Health Names Jeff Keller President of Medical Affairs Division
Propel Health Appoints Veteran Communications Executive Jeff Keller as President of Medical Affairs Business Unit, Signaling Strategic Expansion in Life Sciences Engagement Propel Health, a premier provider of strategic communications…
Fresenius Kabi Honored with 2025 Premier Supplier Legacy Award for Longstanding Excellence
Fresenius Kabi Honored with 2025 Premier Supplier Legacy Award for Continued Excellence in Healthcare Delivery Fresenius Kabi, a leading global healthcare company specializing in lifesaving medicines and technologies, has once…
Astellas Partners with Korean Government-Backed Startup Institute for Global Program
Astellas and Korea’s KISED Forge Strategic Alliance to Support Global Expansion of Drug Discovery Startups Astellas Pharma Inc. (TSE: 4503) has entered into a memorandum of understanding (MoU) with the…
BioNTech Management Board Member Ryan Richardson to Step Down
BioNTech’s Chief Strategy Officer Ryan Richardson to Step Down After Pivotal Seven-Year Tenure BioNTech SE (Nasdaq: BNTX), the German-based global biotechnology company known for its groundbreaking work in mRNA technology…